Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biocorrx Inc (BICX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 23,429
  • Shares Outstanding, K 253,290
  • Annual Sales, $ 660 K
  • Annual Income, $ -29,710 K
  • 36-Month Beta 0.65
  • Price/Sales 37.80
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/15/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0871 +3.33%
on 10/16/18
0.1230 -26.83%
on 09/19/18
-0.0080 (-8.16%)
since 09/17/18
3-Month
0.0500 +80.00%
on 09/12/18
0.1320 -31.82%
on 08/24/18
-0.0400 (-30.77%)
since 07/17/18
52-Week
0.0426 +111.27%
on 12/08/17
0.2820 -68.09%
on 01/26/18
-0.0190 (-17.43%)
since 10/17/17

Most Recent Stories

More News
BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001

EQNX::TICKER_START (Other OTC:BICX),(OTC Markets:BICX), EQNX::TICKER_END

BICX : 0.0900 (-2.70%)
BioCorRx Provides BICX102 Grant Update

via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided an update on the grant submitted...

BICX : 0.0900 (-2.70%)
BioCorRx CEO Brady Granier Discusses BioCorRx Recovery Program on This Life #YouLive Podcast Hosted by Dr. Drew

via NEWMEDIAWIRE-- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx...

BICX : 0.0900 (-2.70%)
BioCorRx to Exhibit at the 2nd Annual National Opioid Crisis Management Congress

via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the Company will...

BICX : 0.0900 (-2.70%)
BioCorRx Provides Business Update for the Second Quarter of 2018

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the second quarter ended June...

BICX : 0.0900 (-2.70%)
BioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone Implant

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today reported that Dr. Mark Siegel, commented on the advantages...

BICX : 0.0900 (-2.70%)
BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx CEO, President,...

BICX : 0.0900 (-2.70%)
BioCorRx Provides Business Update for the Full Year Ended 2017

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided a business update for the year ended December...

BICX : 0.0900 (-2.70%)
BioCorRx Partner, Virtual Reality Medical Center, Submits Small Business Innovation Grant Application to the National Institute of Health

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that its partner, Virtual Reality Medical...

STLB : 0.0001 (unch)
BICX : 0.0900 (-2.70%)
Data Shows That the Global Addiction Treatment Market is Set to Grow

Data provided by Transparency Market Research, indicates that global addiction treatment market was valued at approximately US$ 4.0 billion in 2016 and is anticipated to expand at a CAGR of over 6.0% from...

BICX : 0.0900 (-2.70%)
DRRX : 1.05 (+9.37%)
TTNP : 0.24 (+9.59%)
BDSI : 3.74 (-0.27%)
EGLT : 0.1050 (+1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade BICX with:

Key Turning Points

2nd Resistance Point 0.0975
1st Resistance Point 0.0938
Last Price 0.0900
1st Support Level 0.0875
2nd Support Level 0.0849

See More

52-Week High 0.2820
Fibonacci 61.8% 0.1905
Fibonacci 50% 0.1623
Fibonacci 38.2% 0.1341
Last Price 0.0900
52-Week Low 0.0426

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar